Clinical observations that CB2 agonists serve as an adjunct treatment for anxiety [92] could serve that purpose, as two-thirds of individuals with exposure to adversity experience anxiety that precedes their depression [3]. The gene discussed is CNR2; the disease is depressive symptom measurement.